Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetyl Cysteine in Endodontic Revascularization
NCT03451435Phase 1Terminated
- Sponsor
- University of California, Los Angeles
- Start
- Jun 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of acetylcysteine in endodontic disease (2 arms), sponsored by University of California, Los Angeles. Primary endpoint: Change of Root length at 1 year. Started Jun 2018; status: terminated.
02
Drugs
acetylcysteine
03
Conditions
endodontic disease
Beyond the preview
Go deeper on NCT03451435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03451435.